_PRIVATE_LIMITED_491261.webp)
Gitvin Remedies (Gr) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 28-10-2024
- Paid Up Capital ₹ 0.10 M
as on 28-10-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -8.22%
(FY 2023)
- Profit -98.26%
(FY 2023)
- Ebitda -91.45%
(FY 2023)
- Net Worth 24.51%
(FY 2023)
- Total Assets 24.59%
(FY 2023)
About Gitvin Remedies (Gr)
The Corporate was formerly known as Gitvin Remedies Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jigar Chauhan and Dhavalkumar Parmar serve as directors at the Company.
- CIN/LLPIN
U24239GJ2020PTC111845
- Company No.
111845
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Gitvin Remedies (Gr) Private Limited offer?
Gitvin Remedies (Gr) Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder.
Who are the key members and board of directors at Gitvin Remedies (Gr)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jigar Chauhan  | Director | 02-Jan-2020 | Current |
| Dhavalkumar Parmar | Director | 02-Jan-2020 | Current |
Financial Performance of Gitvin Remedies (Gr).
Gitvin Remedies (Gr) Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.22% decrease. The company also saw a substantial fall in profitability, with a 98.26% decrease in profit. The company's net worth Soared by an impressive increase of 24.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gitvin Remedies (Gr)?
In 2023, Gitvin Remedies (Gr) had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gitvin Remedies (Gr)?
Unlock and access historical data on people associated with Gitvin Remedies (Gr), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gitvin Remedies (Gr), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gitvin Remedies (Gr)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
